Search for: "Railway Company v. Philadelphia"
Results 1 - 14
of 14
Sort by Relevance
|
Sort by Date
12 Dec 2023, 5:00 am
Nov. 22, 2023), the court determined that venue was proper in Philadelphia County even though the only 0.005% of the defendant company’s national revenue was derived from that county. [read post]
28 Aug 2023, 1:23 pm
Co. of Philadelphia v. [read post]
10 Jul 2023, 9:01 pm
Co. of Philadelphia v. [read post]
8 Mar 2023, 6:38 am
Norfolk Southern Railway Co. [read post]
7 Mar 2023, 5:30 am
The post <i>Mallory v. [read post]
3 Mar 2023, 3:00 am
National/Federal Indian Americans Rapidly Climbing Political Ranks DNyuz – Maggie Astor and Jill Cowan (New York Times) | Published: 2/27/2023 Despite being one of the largest immigrant groups in the U.S., Americans of Indian descent in 20123 were barely represented in politics. [read post]
8 Nov 2022, 1:27 pm
Carter Phillips argues for Norfolk Southern Railway Company. [read post]
7 Nov 2022, 12:09 pm
Mallory also points to the Supreme Court’s 1917 decision in Pennsylvania Fire Insurance Co. of Philadelphia v. [read post]
7 Dec 2017, 3:30 am
Rather, in Burlington Northern & Santa Fe Railway Co. v. [read post]
1 Sep 2015, 6:07 am
This point includes relevant text of a recent decision of the European Court of Human Rights, Eweida and Others v. [read post]
27 Jan 2012, 8:45 am
Following the decision in Massachusetts v. [read post]
14 Mar 2010, 10:47 pm
– Dawn Harris-Young, EPA, March 8, 2010 Norfolk Southern Railway Company has agreed to pay $4 million penalty to resolve alleged violations of the Clean Water Act (CWA) and hazardous materials laws for a 2005 chlorine spill in Graniteville, S.C., the Justice Department and U.S. [read post]
29 Oct 2009, 8:41 am
BNSF Railway Co., 2009 WL 2731154 (D. [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’ still… [read post]